Cell Therapy

Is WGS the Key to Unlocking PARP Inhibitor Therapy?
Research & Development Is WGS the Key to Unlocking PARP Inhibitor Therapy?

A comprehensive and detailed analysis from a recent study is reshaping the landscape of precision oncology, revealing the significant potential of whole-genome sequencing (WGS) to revolutionize how patient responses to PARP inhibitor cancer treatments are predicted. The findings, published in the

Which Gene Therapy Is Best for Sickle Cell Disease?
Research & Development Which Gene Therapy Is Best for Sickle Cell Disease?

With the recent regulatory approval of two distinct gene therapies for sickle cell disease, patients and clinicians now face a pivotal and complex question regarding which groundbreaking treatment offers the best long-term solution. A landmark preclinical study published in Blood Advances provides

Genetic Study Finds Caffeine May Lower Fat and Diabetes Risk
Research & Development Genetic Study Finds Caffeine May Lower Fat and Diabetes Risk

The daily ritual of drinking coffee or tea may hold deeper health implications than previously understood, and the secret appears to lie not in the cup, but within our own DNA. A landmark study leveraging large-scale genetic data has uncovered a compelling causal link between the way an

Pain Neurons Actively Command Bone Repair
Research & Development Pain Neurons Actively Command Bone Repair

A fractured bone unleashes an immediate and intense cascade of pain signals, but new evidence compellingly suggests these very same messengers are also the architects of their own repair. For decades, the nervous system's role in skeletal injury was viewed through a narrow lens: nerves reported

Scientists Unlock Production of Crucial Helper T Cells
Research & Development Scientists Unlock Production of Crucial Helper T Cells

The era of living medicines has dawned with treatments that can melt away once-untreatable cancers, yet this revolutionary power remains locked away from the vast majority of patients who need it. These advanced cellular immunotherapies, while miraculously effective for some, are hobbled by a

Study Pinpoints Cellular Origin of Common Brain Cancer
Research & Development Study Pinpoints Cellular Origin of Common Brain Cancer

We are joined by biopharma expert Ivan Kairatov to discuss a groundbreaking discovery that redefines our understanding of IDH-mutant glioma, the most common malignant brain tumor in young adults. This conversation explores how this cancer begins not as a visible mass, but as a stealthy infiltration

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later